Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec;172(2):125-132.
doi: 10.1007/s10517-021-05348-4. Epub 2021 Dec 2.

Expression of Circulating Rennin-Angiotensin-Aldosterone-Related microRNAs in Patients with Thyrotoxic Heart Disease

H M Li  1   2 , Y X Chen  3 , X M Fan  1 , L L Chen  2
Affiliations

Expression of Circulating Rennin-Angiotensin-Aldosterone-Related microRNAs in Patients with Thyrotoxic Heart Disease

H M Li et al. Bull Exp Biol Med. 2021 Dec.

Abstract

Thyrotoxic heart disease (THD) is a common and severe complication of hyperthyroidism and the etiology of this complication remains poorly understood. Activation of the rennin-angiotensin- aldosterone system by excess thyroxin is one of the major factors that contribute to the pathogenesis of THD. Several microRNAs such as miR-21, miR-155, miR-208a, and miR-499 are closely related to the rennin-angiotensin-aldosterone system and therefore should be involved in this process. Our study intends to explore whether these miRNAs are involved in the pathogenesis of THD, and if these miRNAs could be secreted into the circulation and serve as sentinel indicators for THD. Though there is a trend of elevation of miR- 155 in THD than in simple hyperthyroidism patients, we did not find statistically significant differences in the expression of these miRNAs in the blood of THD patients, but we found that miR-155 was significantly up-regulated in patients with Graves' disease with or without THD in comparison with healthy controls. Thus, miR-155 can serve as a novel biomarker for Graves' disease and can play important roles in pathogenesis of Graves' disease.

Keywords: miR-155; microRNA; rennin—angiotensin—aldosterone system; thyrotoxic heart disease.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Barreto-Chaves ML, Senger N, Fevereiro M, Parletta AC, Takano A. Impact of hyperthyroidism on cardiac hypertrophy. Endocr. Connect. 2020;9(3):R59-R69. doi: https://doi.org/10.1530/EC-19-0543 - DOI - PMC
    1. Carneiro-Ramos MS, Diniz GP, Nadu AP, Almeida J, Vieira RL, Santos RA, Barreto-Chaves ML. Blockage of angiotensin II type 2 receptor prevents thyroxine-mediated cardiac hypertrophy by blocking Akt activation. Basic Res. Cardiol. 2010;105(3):325-335. doi: https://doi.org/10.1007/s00395-010-0089-0 - DOI - PubMed
    1. Chen LY, Wang X, Qu XL, Pan LN, Wang ZY, Lu YH, Hu HY. Activation of the STAT3/microRNA-21 pathway participates in angiotensin II-induced angiogenesis. J. Cell. Physiol. 2019;234(11):19640-19654. doi: https://doi.org/10.1002/jcp.28564 - DOI - PubMed - PMC
    1. Diniz GP, Lino CA, Moreno CR, Senger N, Barreto-Chaves MLM. MicroRNA-1 overexpression blunts cardiomyocyte hypertrophy elicited by thyroid hormone. J. Cell Physiol. 2017;232(12):3360-3368. doi: https://doi.org/10.1002/jcp.25781 - DOI - PubMed
    1. Diniz GP, Takano AP, Barreto-Chaves ML. MiRNA-208a and miRNA-208b are triggered in thyroid hormone-induced cardiac hypertrophy - role of type 1 Angiotensin II receptor (AT1R) on miRNA-208a/α-MHC modulation. Mol. Cell. Endocrinol. 2013;374(1-2):117-124. doi: https://doi.org/10.1016/j.mce.2013.04.010 - DOI - PubMed

Substances

LinkOut - more resources